Live
- Hackers attacked Indian firms on average 2,444 times per week in last 6 months: Report
- US election outcome not to change direction of South Korea-US alliance: Seoul envoy
- 'Manipur Super 50' scores big in providing opportunities to the state's youth
- L&T Technology Services logs Rs 1,304 crore in net profit in FY24
- Rajya Sainik Board-Kolkata empowers deceased veteran's daughter with mobility
- BJP complains to ECI against Abhishek Banerjee for 'abusive' remarks against party candidate
- IPL 2024: RCB elect to bat first against in-form Sunrisers
- Selectors likely to name squad for T20 World Cup this weekend, say BCCI sources
- 'Democracy is crying', Mamata Banerjee sharpens attack against HC ruling in school jobs case
- Vet student 'suicide': Kerala HC dismisses suspended VC's petition challenging action against him
Hydroxychloroquine may not be effective: Chinese study
Beijing: To treat people infected with the coronavirus (COVID-19), many, including the US President Donald Trump, have supported the use of the...
Beijing: To treat people infected with the coronavirus (COVID-19), many, including the US President Donald Trump, have supported the use of the anti-malarial drug hydroxychloroquine (HCQ).
However, the antimalarial drug might not be effective in treating coronavirus (COVID-19), claims a Chinese study. Hydroxychloroquine is used to prevent and treat acute attacks of malaria. It is also used to treat discoid or systemic lupus erythematosus and rheumatoid arthritis in patients whose symptoms have not improved with other treatments.
The anti-malarial drug has been identified by the US Food and Drug Administration (FDA) as a potential treatment for the coronavirus. For the findings, the researchers from china picked 150 hospitalised patients and conducted a randomised controlled trial at 16 government-designated COVID-19 treatment centres.
